Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
8390911
Reference Type
Journal Article
Title
Effectiveness of amylmetacresol and 2,4-dichlorobenzyl alcohol throat lozenges in patients with acute sore throat due to upper respiratory tract infection: A systematic review protocol
Author(s)
Tan, TW; Chen, BC; Tan, HL; Chang, CM
Year
2017
Publisher
Joanna Briggs Institute
Volume
15
Issue
4
Page Numbers
862-872
Language
English
DOI
10.11124/JBISRIR-2016-003034
Abstract
Review question/objective: This review aims to determine the best available evidence related to the effectiveness of amylmetacresol and 2,4-dichlorobenzyl alcohol throat lozenges in patients with acute sore throat due to upper respiratory tract infection (URTI). The objective is to examine the analgesic properties of amylmetacresol and 2,4-dichlorobenzyl alcohol (AMC/DCBA) throat lozenge comparing with placebo for the relief of pain in patients with acute sore throat due to URTIs. The review question is: Are amylmetacresol (AMC 0.6 mg) and 2,4-dichlorobenzyl (DCBA 1.2-mg) alcohol throat lozenges effective in relieving acute sore throat caused by URTIs? More specifically, the objectives are to: Evaluate changes in severity of throat soreness Evaluate the pain relief ratings Measure functional difficulty in swallowing Measure functional throat numbness. © 2017 THE JOANNA BRIGGS INSTITUTE.
Keywords
2,4-dichlorobenzyl alcohol; Amylmetacresol; Lozenge; Respiratory infection; Sore throat
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity